Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell metabolism"
DOI: 10.1016/j.cmet.2018.11.012
Abstract: Metformin is a first-line glucose-lowering agent in patients with type 2 diabetes (T2D). Recently in Nature Medicine, Sun et al. (2018) reported that short-term metformin therapy decreases gut Bacteroides fragilis, consequently increasing glycoursodexoycholic acid (GUDCA) levels…
read more here.
Keywords:
feeling metformin;
medicine;
metformin;
gut feeling ... See more keywords